Income Statement

v3.10.0.1
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
3 Months Ended
Dec. 31, 2018
Dec. 31, 2017
REVENUES    
Total revenues $ 387,100 $ 122,000
Cost of revenues 225,100 84,900
GROSS MARGIN 162,000 37,100
OPERATING EXPENSES    
Research 80,800 81,500
Product development 237,000 269,200
Sales and marketing 151,900 667,200
General and administrative 2,373,800 1,774,800
Total operating expenses 2,843,500 2,792,700
OPERATING LOSS (2,681,500) (2,755,600)
OTHER INCOME (EXPENSE):    
Interest expense, net (22,900) (13,700)
Total other income (expense) (22,900) (13,700)
LOSS BEFORE PROVISION FOR INCOME TAXES (2,704,400) (2,769,300)
Income taxes
NET LOSS (2,704,400) (2,769,300)
Net loss attributable to noncontrolling interest (326,900)
Net Loss attributable to MYnd Analytics, Inc. $ (2,377,500) $ (2,769,300)
BASIC AND DILUTED LOSS PER SHARE: (in dollars per share) $ (0.32) $ (0.64)
WEIGHTED AVERAGE SHARES OUTSTANDING:    
Basic and Diluted (in shares) 7,542,663 4,332,927
Neurometric Services [Member]    
REVENUES    
Total revenues $ 79,200 $ 53,300
Cost of revenues 6,400 49,100
Telepsychiatry Services [Member]    
REVENUES    
Total revenues 307,900 68,700
Cost of revenues $ 218,700 $ 35,900

Source